Astal Laboratories Share Price
54.27+3.02 (+5.89%)
-44.40% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
ASTALLTD-XNSE
Astal Laboratories Share Price
54.27+3.02 (+5.89%)
-44.40% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 289% |
| - | - | - | 65% |
| - | - | - | -47% |
| 18% | 18% | 18% | 8% |
Peer Comparison
Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
LAURUSLABS-A
ZYDUSLIFE-A
DRREDDY-A
CIPLA-A
MANKIND-A
AUROPHARMA-A
LUPIN-A
ASTALLTD-X
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,788.9 | ₹425150 Cr | 38.77 | 8.29 | 58.23 | ₹11479 Cr |
| 9,981.5 | ₹266265 Cr | 91.03 | 34.04 | 128.41 | ₹2568 Cr |
| 4,640 | ₹176301 Cr | 83 | 14.04 | 106.21 | ₹2163 Cr |
| 2,319.4 | ₹125352 Cr | 93.56 | 8.17 | 33.94 | ₹889 Cr |
| 1,260 | ₹123591 Cr | 27.39 | 9.42 | 62.53 | ₹5040 Cr |
| 1,374.5 | ₹114351 Cr | 40.84 | 11.08 | 59.2 | ₹4196 Cr |
| 1,395.9 | ₹112474 Cr | 38.82 | 10.86 | 52.6 | ₹3879 Cr |
| 2,486 | ₹102315 Cr | 45.62 | 17.23 | 76.26 | ₹1913 Cr |
| 1,701.6 | ₹97757 Cr | 26.33 | 17.95 | 96.84 | ₹3505 Cr |
| 2,020.5 | ₹92007 Cr | 16.64 | 30.95 | 154.35 | ₹5333 Cr |
| 54.55 | ₹224 Cr | 15.26 | 2.15 | 3.64 | ₹15 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Mar 2025 |
|---|---|---|
| ₹101 Cr | ₹134 Cr | ₹23 Cr |
| ₹14 L | ₹10 L | ₹4 L |
| ₹101 Cr | ₹134 Cr | ₹24 Cr |
| ₹90 Cr | ₹125 Cr | ₹19 Cr |
| ₹12 Cr | ₹10 Cr | ₹4 Cr |
| ₹1 Cr | ₹1 Cr | ₹27 L |
| ₹10 Cr | ₹8 Cr | ₹4 Cr |
| ₹9 Cr | ₹8 Cr | ₹3 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 |
|---|---|
| — | — |
| ₹42 Cr | ₹10 Cr |
| ₹2 Cr | ₹4 Cr |
| ₹289 Cr | ₹22 Cr |
| ₹289 Cr | ₹22 Cr |
| ₹334 Cr | ₹36 Cr |
| ₹19 Cr | ₹46 L |
| ₹86 L | ₹12 L |
| ₹65 L | ₹0 |
| ₹20 Cr | ₹57 L |
| — | — |
| ₹124 Cr | ₹11 Cr |
| ₹11 Cr | ₹3 Cr |
| ₹30 Cr | ₹13 Cr |
| ₹165 Cr | ₹27 Cr |
| ₹519 Cr | ₹63 Cr |
| ₹49 Cr | ₹13 Cr |
| — | — |
| ₹70 Cr | ₹16 Cr |
| ₹5 Cr | ₹4 Cr |
| ₹64 Cr | ₹11 Cr |
| ₹203 Cr | ₹0 |
| ₹203 Cr | ₹0 |
| ₹4 Cr | ₹4 Cr |
| ₹3 Cr | ₹2 Cr |
| ₹276 Cr | ₹18 Cr |
| — | — |
| ₹68 Cr | ₹15 Cr |
| ₹157 Cr | ₹28 Cr |
| ₹70 L | ₹2 Cr |
| ₹18 Cr | ₹1 Cr |
| ₹243 Cr | ₹46 Cr |
| ₹78 Cr | ₹19 Cr |
| ₹519 Cr | ₹63 Cr |
| ₹79 | ₹33 |
| ₹79 | ₹33 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 |
|---|---|
| ₹18 Cr | ₹12 Cr |
| ₹3 Cr | ₹80 L |
| -₹37 Cr | -₹25 Cr |
| -₹17 Cr | -₹12 Cr |
| -₹18 Cr | -₹13 Cr |
| -₹2 Cr | -₹8 Cr |
| ₹3 Cr | ₹3 Cr |
| -₹17 Cr | -₹17 Cr |
| -₹11 Cr | ₹6 Cr |
| -₹28 Cr | -₹11 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Astal Laboratories Share Price
54.27+3.02 (+5.89%)
-44.40% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 5 out of 9 oscillators
RSI
29.38Sell
STOCH %K
20.37Neutral
MACD Level(12,26)
-4.23Sell
Ultimate Oscillator
35.65Sell
Aroon Oscillator
-96.00Sell
BOP
0.32Buy
CCI
-191.27Buy
Williams %R
-79.63Neutral
Momentum
-12.98Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 9 out of 9 moving averages
EMA 9
59.26Sell
SMA 9
60.73Sell
EMA 21
63.72Sell
SMA 21
64.85Sell
EMA 50
69.11Sell
SMA 50
70.78Sell
EMA 200
76.06Sell
SMA 200
75.56Sell
WMA 20
62.35Sell
Pivot
Pivot
Classic
Resistance 5
72.12
Resistance 4
67.11
Resistance 3
62.10
Resistance 2
57.09
Resistance 1
54.17
Pivot
52.08
Support 1
49.16
Support 2
47.07
Support 3
42.06
Support 4
37.05
Support 5
32.04
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Astal Laboratories Share Price
54.27+3.02 (+5.89%)
-44.40% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 4.59% | 4.53% | 4.70% | 18.19% | 18.19% | 18.19% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 95.41% | 95.47% | 95.30% | 81.81% | 81.81% | 81.81% |
Bulk & block deals
Name
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|
Insider trading & SAST
Client name
Aceso Research Labs Llp
Aceso Research Labs Llp
Aceso Research Labs Llp
Sesha Sai Nikhil Chintalapati
Sesha Sai Nikhil Chintalapati & Others
Kommera Harish
Suryanarayana Raju Rudraraju & Others
Vupparapalli Chandra Sekhar Reddy & Vupparapalli Pavani
Doradla Radha Krishna Huf & Others
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 Sep 2026 | Promoter | Acquisition | 0.060208 | 4.59 | 20 L | ₹78.68 | 25.42 K | 24 Aug 2026 - 08 Sep 2026 | Market Purchase | 20,11,012 | Insider Trading | — | Equity |
| 08 Apr 2026 | Promoter | Acquisition | 0.05 | 4.69 | 0 | — | 21.01 K | 11 Mar 2026 - 19 Mar 2026 | Market | 19,80,291 | SAST | 29(2) | — |
| 19 Mar 2026 | Promoter | Acquisition | 0.213701 | 4.69 | 15.68 L | ₹74.63 | 21.01 K | 11 Mar 2026 - 19 Mar 2026 | Market Purchase | 19,80,291 | Insider Trading | — | Equity Shares |
| 12 Feb 2026 | Other | Acquisition | 11.53 | 11.82 | 0 | — | 48.67 L | 14 Jan 2026 | Pref. Allotment | 49,87,785 | SAST | 29(1) | — |
| 11 Feb 2026 | Other | Acquisition | 11.53 | 11.82 | 0 | — | 48.67 L | 14 Jan 2026 | Pref. Allotment | 49,87,785 | SAST | 29(1) | — |
| 11 Feb 2026 | Other | Acquisition | 6.39 | 6.67 | 0 | — | 26.98 L | 14 Jan 2026 | Pref. Allotment | 28,15,140 | SAST | 29(1) | — |
| 11 Feb 2026 | Other | Acquisition | 7 | 7 | 0 | — | 29.57 L | 14 Jan 2026 | Pref. Allotment | 29,56,666 | SAST | 29(1) | — |
| 11 Feb 2026 | Other | Acquisition | 4.15 | 4.86 | 0 | — | 17.50 L | 14 Jan 2026 | Pref. Allotment | 20,50,000 | SAST | 29(2) | — |
| 11 Feb 2026 | Other | Acquisition | 2.55 | 4.53 | 0 | — | 10.75 L | 14 Jan 2026 | Pref. Allotment | 19,10,370 | SAST | 29(2) | — |
Astal Laboratories Share Price
54.27+3.02 (+5.89%)
-44.40% past 1 Year
Macro International Ltd is engaged in the exporting of goods as well as sales through the departmental stores. The company trades in bridles, halters, rugs, saddles, strip leather, reins, shoes
Corporate Actions
Date
Type
Details
Company details
Astal Laboratories Share Price
54.27+3.02 (+5.89%)
-44.40% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
No presentations found
Astal Laboratories Share Price
54.27+3.02 (+5.89%)
-44.40% past 1 Year
News
Astal Laboratories reports Profit after tax of 1.09 Crores, in the March 2026 quarter
Equity
ASTALLTD
Astal Laboratories informs about disclosure
Equity
ASTALLTD
Astal Laboratories reports Profit after tax of 2.36 Crores, in the December 2025 quarter
Equity
ASTALLTD
Astal Laboratories informs about disclosure
Equity
ASTALLTD
Astal Laboratories informs about disclosure
Equity
ASTALLTD
Astal Laboratories informs about disclosure
Equity
ASTALLTD
Astal Laboratories signs LoI with Immuna Therapeutics GmbH
Equity
ASTALLTD
Astal Laboratories reports Profit after tax of 2.58 Crores, in the September 2025 quarter
Equity
ASTALLTD
Astal Laboratories submits intimation of corrigendum to EGM notice
Equity
ASTALLTD
Astal Laboratories - Quaterly Results
Equity
ASTALLTD
Astal Laboratories - Quaterly Results
Equity
ASTALLTD
Astal Laboratories reports Profit after tax of 2.09 Crores, in the June 2025 quarter
Equity
ASTALLTD
Astal Laboratories reports Profit after tax of 2.74 Crores, in the March 2025 quarter
Equity
ASTALLTD
Astal Laboratories - Quaterly Results
Equity
ASTALLTD
Astal Laboratories - Quaterly Results
Equity
ASTALLTD
Astal Laboratories - Quaterly Results
Equity
ASTALLTD
Astal Laboratories - Quaterly Results
Equity
ASTALLTD
Astal Laboratories - Quaterly Results
Equity
ASTALLTD
Astal Laboratories reports Profit after tax of 2.49 Crores, in the December 2024 quarter
Equity
ASTALLTD
Astal Laboratories informs about disclosures
Equity
ASTALLTD